With pharmaceutical markets expanding globally and companies commercial strategies shifting to the more complex portfolio and access focused models, the nature of the pharmaceutical market is changing. The pharmaceutical companies need to maintain balanced pipelines of products and partnerships to sustain their current commercial performance. The presentation will share some insights into the business development strategy of one of the most dynamic companies in the market and demonstrate the key approaches to portfolio management on a global level.